[Post-marketing surveillance studies].
Copyright policy )[Post-marketing surveillance studies].
Approval of a drug on the market is typically considered as the successful endpoint of a long development phase. This often leads to reduced interest in further research for the indication approved, while in contrast the patient's as well as physician's interest in further research increases. This paper discusses the main areas of effectiveness, safety and post-marketing practice regarding sensible study types for the specific area and the potential gain of knowledge.
Male, Pharmacoepidemiology, Research, Middle Aged, Cohort Studies, Clinical Trials, Phase III as Topic, Case-Control Studies, Product Surveillance, Postmarketing, Humans, Female, Medical Record Linkage, Safety, Aged, Randomized Controlled Trials as Topic
Male, Pharmacoepidemiology, Research, Middle Aged, Cohort Studies, Clinical Trials, Phase III as Topic, Case-Control Studies, Product Surveillance, Postmarketing, Humans, Female, Medical Record Linkage, Safety, Aged, Randomized Controlled Trials as Topic
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).5 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!